Header
For Healthcare Professionals

India: Glyxambi® Patient Profile

Why Glyxambi_Patient CRM_Banner_2x
Metabolism_patient03

Gracy | 40 yrs 

A middle-aged overweight female with uncontrolled
T2DM and sedentary lifestyle

  • Diagnosed with T2DM (1 year ago)
  • Hypertension and Dyslipidemia (>7 years)
  • Current treatment: Metformin, Rosuvastatin and Telmisartan

Laboratory Investigations:

HbA1c 8.5%
 HbA1c: 8.1%
 FBS: 130 mg/dL; PPBS: 220 mg/dL
 BMI: 27 kg/m2; Weight: 70 kg

Weight gain
 LDL-C: 92 mg/dL, HDL-C: 45 mg/dL, TG: 210 mg/dL
 BP: 130/80 mmHg
 Normal renal function
Cardio_patient01

George | 58 yrs 

A late middle-aged Male with uncontrolled T2DM and H/O CAD

  • History of CAD (5 years)
  • T2DM (1 year) & Hypertension (>20 years)
  • Breathlessness on exertion (NYHA Class II)
  • On treatment: Metformin, antihypertensives, Statins and Aspirin

Laboratory Investigations:

HbA1c 8.5%
 HbA1c: 8.1%,
 FBS: 130/ PPBS: 220
 NT-proBNP: 510 pg/mL
 Echocardiography: LVEF 50%, grade 3 diastolic dysfunction
High CVDHF risk
 Urine albumin-creatinine ratio: 360 mg/g
 Serum creatinine: 1.4 mg/dL;
 eGFR: 58 mL/min/1.73m2
 BMI: 28 KG/M2
 Weight: 80 kg
 BP: 130/80 mmHg
 TG: 180 mg/dL
Renal_patient02

Girish | 58 yrs 

A late middle-aged Male with DKD & long-standing HTN

  • T2DM (2 years)
  • Long-standing HTN + Dyslipidemia (>20 years)
  • Current treatment: Metformin, Atrovastatin, Telmisartan, Amlodipine & Hydrochlorothiazide

Laboratory Investigations:

DKD
 HbA1c: 8.2%
 FBS: 144 mg/dL; PPBS: 246 mg/dL
 Urine albumin-creatinine ratio: 180 mg/g
 Serum Creatinine: 1.4 mg/dL
 eGFR: 58 mL/min/1.73 m2
 
HbA1c 8.5%
 BMI: 28 kg/m2 | Weight: 80 kg
 LDL: 88 mg/dL | TG: 180 mg/dL
high bp
BP: 140/90 mmHg
  • *
    DKD: Diabetes Kidney Disease; HTN: Hypertension

  1. GLYXAMBI® India pack insert version. 15 May 2024.